Literature DB >> 22132885

Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.

S U Patil1, W G Shreffler.   

Abstract

Allergen-specific immunotherapy is an effective clinical treatment for hypersensitivity to many allergens. Studies of basophils during immunotherapy have provided insight into underlying immune mechanisms and support the potential use of basophil activation as a biomarker of clinical outcomes. This review examines the evidence for different pathways of basophil modulation associated with various forms of immunotherapy. Better understanding the molecular mechanisms of basophil activation and desensitization and the relationship between suppression of these effector cells to clinical outcomes holds promise for further development and improvement in potential therapies for allergic diseases.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22132885      PMCID： PMC3248087          DOI： 10.1111/j.1365-2249.2011.04503.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  64 in total

1.  Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

Authors:  James N Francis; Louisa K James; Giannis Paraskevopoulos; Cheukyee Wong; Moises A Calderon; Stephen R Durham; Stephen J Till
Journal:  J Allergy Clin Immunol       Date:  2008-04-18       Impact factor: 10.793

2.  Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.

Authors:  E Gadermaier; J Staikuniene; S Scheiblhofer; J Thalhamer; M Kundi; K Westritschnig; I Swoboda; S Flicker; R Valenta
Journal:  Allergy       Date:  2011-04-11       Impact factor: 13.146

3.  Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

Authors:  Louisa K James; Mohamed H Shamji; Samantha M Walker; Duncan R Wilson; Petra A Wachholz; James N Francis; Mikila R Jacobson; Ian Kimber; Stephen J Till; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

4.  Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy.

Authors:  N Lalek; M Kosnik; M Silar; P Korosec
Journal:  Clin Exp Allergy       Date:  2010-05-31       Impact factor: 5.018

5.  Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo.

Authors:  M Paterniti; D C Kelly; J A Eckman; P M Sterba; R G Hamilton; B S Bochner; D W Macglashan; S S Saini
Journal:  Clin Exp Allergy       Date:  2011-03-29       Impact factor: 5.018

6.  A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.

Authors:  Daocheng Zhu; Christopher L Kepley; Min Zhang; Ke Zhang; Andrew Saxon
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

7.  Expression of activation markers on basophils in a controlled model of anaphylaxis.

Authors:  Laura M Gober; John A Eckman; Patricia M Sterba; Kavitha Vasagar; John T Schroeder; David B K Golden; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2007-03-01       Impact factor: 10.793

8.  IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.

Authors:  Carol T Cady; Maree S Powell; Ronald J Harbeck; Patricia C Giclas; James R Murphy; Rohit K Katial; Richard W Weber; P Mark Hogarth; Syd Johnson; Ezio Bonvini; Scott Koenig; John C Cambier
Journal:  Immunol Lett       Date:  2009-12-30       Impact factor: 3.685

9.  Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.

Authors:  Friedrich Horak; Petra Zieglmayer; René Zieglmayer; Patrick Lemell; Philippe Devillier; Armelle Montagut; Michel Mélac; Sylvie Galvain; Stéphanie Jean-Alphonse; Laurence Van Overtvelt; Philippe Moingeon; Martine Le Gall
Journal:  J Allergy Clin Immunol       Date:  2009-08-03       Impact factor: 10.793

10.  Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.

Authors:  R Schubert; O Eickmeier; H Garn; P C Baer; T Mueller; J Schulze; M A Rose; M Rosewich; H Renz; S Zielen
Journal:  Int Arch Allergy Immunol       Date:  2008-10-10       Impact factor: 2.749
View more
  22 in total

1.  Data-driven programmatic approach to analysis of basophil activation tests.

Authors:  Sarita U Patil; Agustin Calatroni; Michael Schneider; Johanna Steinbrecher; Neal Smith; Cecilia Washburn; Alex Ma; Wayne G Shreffler
Journal:  Cytometry B Clin Cytom       Date:  2017-07-05       Impact factor: 3.058

2.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 3.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 4.  Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.

Authors:  Jared M Odegard; Gerald T Nepom; Erik Wambre
Journal:  Clin Immunol       Date:  2015-06-27       Impact factor: 3.969

5.  Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.

Authors:  Sarita U Patil; Johanna Steinbrecher; Agustin Calatroni; Neal Smith; Alex Ma; Bert Ruiter; Yamini Virkud; Michael Schneider; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2019-08-01       Impact factor: 10.793

6.  New modalities of allergen immunotherapy.

Authors:  Manish Ramesh; Merhunisa Karagic
Journal:  Hum Vaccin Immunother       Date:  2018-09-14       Impact factor: 3.452

Review 7.  Emerging Food Allergy Biomarkers.

Authors:  Sarita U Patil; Supinda Bunyavanich; M Cecilia Berin
Journal:  J Allergy Clin Immunol Pract       Date:  2020-09

8.  Validation of inducible basophil biomarkers: Time, temperature and transportation.

Authors:  Theodore Kim; Jing Yu; Henry Li; Mark Scarupa; Richard L Wasserman; Athena Economides; Martha White; Carla Ward; Atul Shah; Douglas Jones; Melinda Rathkopf; Kelly Frye; Ahmet Aybar; Shahrooz Shayegan; Benjamin Enav; Laura Ispas; Denise Loizou; David Fitzhugh; James Tracy; James Friedlander; Zachary Jacobs; Jonathan Matz; David Golden; Donald McNeil; William McCann; Christopher Copenhaver; Jeffrey Factor; Raavi Gupta; Oral Alpan; Matthew Plassmeyer; Søren Ulrik Sønder
Journal:  Cytometry B Clin Cytom       Date:  2021-02-04       Impact factor: 3.248

9.  Differences in IgE mediated basophil degranulation induced by proteic fractions from whole flea body extract in patients with papular urticaria by flea bite and healthy controls.

Authors:  Omar Dominguez-Amorocho; Silvia Duarte; Elizabeth Garcia; Evelyne Halpert; Adriana Cuellar; Adriana Rodriguez
Journal:  World Allergy Organ J       Date:  2013-05-16       Impact factor: 4.084

Review 10.  Basophil activation test in food allergy: is it ready for real-time?

Authors:  Tarun Keswani; Sarita U Patil
Journal:  Curr Opin Allergy Clin Immunol       Date:  2021-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.